CORRELATION OF GLUCOSE CONSUMPTION AND TUMOR-CELL DENSITY IN ASTROCYTOMAS - A STEREOTAXIC PET STUDY

被引:124
作者
HERHOLZ, K
PIETRZYK, U
VOGES, J
SCHRODER, R
HALBER, M
TREUER, H
STURM, V
HEISS, WD
机构
[1] MAX PLANCK INST NEUROL RES,DEPT STEREOTAXY & FUNCT NEUROSURG,NEUROL CLIN,GLEUELER STR 50,D-50931 COLOGNE,GERMANY
[2] UNIV COLOGNE,INST PATHOL,W-5000 COLOGNE 41,GERMANY
关键词
ASTROCYTOMA; GLUCOSE METABOLISM; CELL DENSITY; POSITRON EMISSION TOMOGRAPHY;
D O I
10.3171/jns.1993.79.6.0853
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
To determine histological correlates of the variability of glucose consumption in astrocytomas, the authors performed positron emission tomography (PET) with F-18-2-fluoro-2-deoxy-D-glucose (FDG) and matched the PET scans three-dimensionally with computerized tomography scans obtained in a stereotactic frame before biopsy. Ten patients with astrocytomas of World Health Organization Grade 2 or 3 were studied; patients with glioblastomas, oligodendrogliomas, or oligoastrocytomas were excluded from the study to avoid any confounding effects of different cell types and necroses. In samples of pure tumor, glucose consumption correlated significantly with cell density, but not with nuclear polymorphism. It is concluded that tumor cell density is a major determinant of glucose consumption in astrocytomas. The use of PET with FDG may help to locate the highest cell density and thus improve the diagnostic yield of stereotactic biopsy.
引用
收藏
页码:853 / 858
页数:6
相关论文
共 34 条
[1]  
BACKLUND EO, 1971, ACTA CHIR SCAND, V137, P825
[2]   APPARENT GLUCOSE-UTILIZATION IN WALKER 256 METASTATIC BRAIN-TUMORS [J].
BLASBERG, RG ;
SHINOHARA, M ;
SHAPIRO, WR ;
PATLAK, CS ;
PETTIGREW, KD ;
FENSTERMACHER, JD .
JOURNAL OF NEURO-ONCOLOGY, 1986, 4 (01) :5-16
[3]   THE USE OF THE MONOCLONAL-ANTIBODY KI-67 IN THE IDENTIFICATION OF PROLIFERATING CELLS - APPLICATION TO SURGICAL NEUROPATHOLOGY [J].
BURGER, PC ;
SHIBATA, T ;
KLEIHUES, P .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1986, 10 (09) :611-617
[4]  
DICHIRO G, 1987, INVEST RADIOL, V22, P360
[5]   GLUCOSE-UTILIZATION OF CEREBRAL GLIOMAS MEASURED BY [F-18] FLUORODEOXYGLUCOSE AND POSITRON EMISSION TOMOGRAPHY [J].
DICHIRO, G ;
DELAPAZ, RL ;
BROOKS, RA ;
SOKOLOFF, L ;
KORNBLITH, PL ;
SMITH, BH ;
PATRONAS, NJ ;
KUFTA, CV ;
KESSLER, RM ;
JOHNSTON, GS ;
MANNING, RG ;
WOLF, AP .
NEUROLOGY, 1982, 32 (12) :1323-1329
[6]   CEREBRAL NECROSIS AFTER RADIOTHERAPY AND OR INTRAARTERIAL CHEMOTHERAPY FOR BRAIN-TUMORS - PET AND NEUROPATHOLOGIC STUDIES [J].
DICHIRO, G ;
OLDFIELD, E ;
WRIGHT, DC ;
DEMICHELE, D ;
KATZ, DA ;
PATRONAS, NJ ;
DOPPMAN, JL ;
LARSON, SM ;
ITO, M ;
KUFTA, CV .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1988, 150 (01) :189-197
[7]   CAPACITY FOR SUBSTRATE UTILIZATION IN OXIDATIVE-METABOLISM BY NEURONS, ASTROCYTES, AND OLIGODENDROCYTES FROM DEVELOPING BRAIN IN PRIMARY CULTURE [J].
EDMOND, J ;
ROBBINS, RA ;
BERGSTROM, JD ;
COLE, RA ;
DEVELLIS, J .
JOURNAL OF NEUROSCIENCE RESEARCH, 1987, 18 (04) :551-561
[8]   IDENTIFICATION OF EARLY RECURRENCE OF PRIMARY CENTRAL-NERVOUS-SYSTEM TUMORS BY [F-18] FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY [J].
GLANTZ, MJ ;
HOFFMAN, JM ;
COLEMAN, RE ;
FRIEDMAN, AH ;
HANSON, MW ;
BURGER, PC ;
HERNDON, JE ;
MEISLER, WJ ;
SCHOLD, SC .
ANNALS OF NEUROLOGY, 1991, 29 (04) :347-355
[9]  
HABERKORN U, 1991, J NUCL MED, V32, P1548
[10]   FDG-PET IN THE SELECTION OF BRAIN-LESIONS FOR BIOPSY [J].
HANSON, MW ;
GLANTZ, MJ ;
HOFFMAN, JM ;
FRIEDMAN, AH ;
BURGER, PC ;
SCHOLD, SC ;
COLEMAN, RE .
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1991, 15 (05) :796-801